Cargando…
In vitro cytochrome P450‐ and transporter‐mediated drug interaction potential of 6β‐hydroxy‐21‐desacetyl deflazacort—A major human metabolite of deflazacort
6β‐Hydroxy‐21‐desacetyl deflazacort (6β‐OH‐21‐desDFZ) is a major circulating but not biologically active metabolite of deflazacort (DFZ). In vitro studies were performed to evaluate cytochrome P450 (CYP)‐ and transporter‐mediated drug interaction potentials of 6β‐OH‐21‐desDFZ. Up to 50 µM, the highe...
Autores principales: | Ma, Jiyuan, Beers, Brian, Manohar, Ravi, Roe, Stephen, Colacino, Joseph M., Kong, Ronald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7982320/ https://www.ncbi.nlm.nih.gov/pubmed/33749127 http://dx.doi.org/10.1002/prp2.748 |
Ejemplares similares
-
Metabolite V, an epoxide species is a minor circulating metabolite in humans following a single oral dose of deflazacort
por: Kong, Ronald, et al.
Publicado: (2020) -
Deflazacort-induced Acneiform Eruptions
por: Bashir, Mohammed Shakeel Mohammed, et al.
Publicado: (2017) -
DEFLAZACORT VERSUS OTHER GLUCOCORTICOIDS: A COMPARISON
por: Nayak, Surajit, et al.
Publicado: (2008) -
Deflazacort in comparison to other steroids for nephrotic syndrome
por: Jat, K. R., et al.
Publicado: (2012) -
Skeletal Muscle Response to Deflazacort, Dexamethasone and Methylprednisolone
por: Fappi, Alan, et al.
Publicado: (2019)